Medical Radiology and Radiation Safety. 2025. Vol. 70. № 1
DOI:10.33266/1024-6177-2025-70-1-67-73
A.V. Vertinskiy1, 2, E.A. Selikhova2, E.S. Sukhikh2, 3, V.V. Velikaya3,
O.V. Gribova3, Zh.A. Starceva3
Modernized Software for Calculation and Optimization
of Absorbed Dose Distribution in a Homogeneous Medium during Radiation Therapy with Fast Neutrons
1Tomsk Regional Oncology Center, Tomsk, Russia
2 National Research Tomsk Polytechnic University, Tomsk, Russia
3Tomsk National Research Medical Center, Tomsk, Russia
Contact person: A.V. Vertinskiy, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
ABSTRACT
Purpose: To modernize software for calculation and optimization of isoeffective and absorbed dose distributions in a homogeneous media when planning fast neutron therapy for malignant tumours.
Material and Methods: The updated absorbed dose calculation system was applied to patients with two localisations, breast cancer (BC) and head and neck cancer (HNC). The study included data from 12 patients, of which 7 were patients with primary locally advanced breast cancer and 5 patients with head and neck cancer. In patients with BC, comprehensive treatment was performed. Patients with malignant tumours of the head and neck region underwent neutron and neutron-photon radiation therapy both in terms of combined treatment and as an independent type of treatment. Breast cancer was irradiated in fractionation mode with 4 fractions of 1.6 Gy each. Field docking was used. Patients diagnosed with head and neck cancer were irradiated in the mode of 3 fractions with a single dose of 2.4 Gy with the duration of the full course of treatment of 8 days. Irradiation took place on the therapeutic channel of the U-120 cyclotron located at Tomsk Polytechnic University.
Results: The planning results showed that the dose to the skin in the irradiation zone was 3.190 Gy and 3.143 Gy for beams 1 and 2, respectively. In the tumour centre, the dose was 3.253 Gy (isoeffective dose 7.980 isoGy). For critical sites (heart), the maximum doses ranged from 0.507 Gy to 1.943 Gy. ). The duration of exposure from each beam was 4 minutes and 26 seconds. For five patients with cancer in the head and neck region, planning was performed using 2 fields separated by an angle of 90 degrees (irradiation angles of 45 and 315 degrees). The fractionation regime included: 3 sessions with tumour dose 2.4 Gy, total dose 7.2 Gy per treatment course. The full course of neutron therapy was carried out in 8 days. TDF in the tumour zone was 55.4 units, with the maximum permissible value of 130 units. As a result, the dose to the skin was from 5.8 to 7.5 Gy. The dose to the tumour centre ranged from 7.1 to 7.23 Gy (taking into account RBE = 2.686 isoeffective dose ranged from 37.9 to 38.4 isoGy). Total treatment time per fraction was from 12.3 to 13.5 minutes.
Keywords: radiation therapy, fast neutron, dosimetric planning, modeling of absorbed dose distribution, U-120 cyclotron, breast cancer, head and neck malignant neoplasms
For citation: Vertinskiy AV, Selikhova EA, Sukhikh ES, Velikaya VV, Gribova OV, Starceva ZhA. Modernized Software for Calculation and Optimization of Absorbed Dose Distribution in a Homogeneous Medium during Radiation Therapy with Fast Neutrons. Medical Radiology and Radiation Safety. 2025;70(1):67–73. (In Russian). DOI:10.33266/1024-6177-2025-70-1-67-73
References
1. Sedov V.P., Lisin V.A. Model of VDF for Distant Therapy of Malignant Tumors with Fast Neutrons. Meditsinskaya Radiologiya = Medical Radiology 1988;33;9:9-12 (In Russ.).
2. Lisin V.A. Linear-Quadratic Model in Planning Neutron Therapy at the U-120 Cyclotron. Meditsinskaya Radiologiya i Radiatsionnaya Bezopasnost’ = Medical Radiology and Radiation Safety. 2018;63;5:41-47 (In Russ.)
3. Lisin V.A. Dosimetric Computer Planning of Gamma-Neutron Therapy of Malignant Tumors Using the U-120 Cyclotron. Meditsinskaya Radiologiya i Radiatsionnaya Bezopasnost’ = Medical Radiology and Radiation Safety. 1994;39;5:53-57 (In Russ.).
4. Choynzonov Ye.L., Lisin V.A., Gribova O.V., Novikov V.A., Startseva Zh.A. Neytronnaya Terapiya Zlokachestvennykh Novoobrazovaniy Golovy i Shei = Neutron Therapy of Malignant Neoplasms of the Head and Neck: Monograph. Moscow, Rossiyskaya Akademiya Nauk Publ., 2021. 328 p. (In Russ.).
5. Startseva Zh.A., Gribova O.V., Velikaya V.V., Sukhikh Ye.S., Lisin V.A., Novikov V.A. Remote Neutron Therapy in Tomsk: 40 Years in the Service of Oncology. Sibirskiy Onkologicheskiy Zhurnal = Siberian Oncology Journal. 2024;23;1:98-108.
6. Velikaya V.V., Startseva Zh.A., Gol’dberg V.Ye., Popova N.O. Ten-Year Results of Complex Treatment of Patients with Primary Locally Advanced Breast Cancer. Meditsinskaya Radiologiya i Radiatsionnaya Bezopasnost’ = Medical Radiology and Radiation Safety. 2023;68;5:71-76.
7. Musabaeva L.I., Startseva Zh.A., Gribova O.V., Velikaya V.V., Lisin V.A. Novel Technologies and Theoretical Models in Radiation Therapy of Cancer Patients Using 6.3 MeV Fast Neutrons Produced BY U-120 Cyclotron. Proceedings of the International Conference on Physics of Cancer: Interdisciplinary Problems and Clinical Applications 2016. 22–25 March 2016. Russia, Tomsk.
8. Musabayeva L.I., Choynzonov Ye.L., Gribova O.V., Startseva ZH.A., Velikaya V.V., Lisin V.A. Neutron Therapy in the Treatment of Radioresistant Malignant Neoplasms. Sibirskiy Onkologicheskiy Zhurnal = Siberian Oncological Journal. 2016;15;3:67-71 (In Russ.).
9. Gribova O.V., Musabayeva L.I., Choynzonov Ye.L., Mukhamedov M.R. Clinical Course of Thyroid Cancer after Combined Treatment with Fast Neutrons in Patients with a High Risk of Recurrence. Vestnik Otorinolaringologii = Bulletin of Otolaryngology. 2012;5:91-92 (In Russ.).
10. Ellis F. Dose. time and fractionation: A clinical hypothesis // Clin. Radiol. 1969. Vol. 20. P. 1‒7.
PDF (RUS) Full-text article (in Russian)
Conflict of interest. The authors declare no conflict of interest.
Financing. The study had no sponsorship.
Contribution. Article was prepared with equal participation of the authors.
Article received: 20.10.2024. Accepted for publication: 25.11.2024.